Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Vitamin D: Health Panacea or false Prophet?
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
Morning glory syndrome associated with multiple sclerosis.
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
Current options for the treatment of optic neuritis.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Clinical profile and short-term outcomes of optic neuritis patients in India.
The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research.
Mind-body medicine for multiple sclerosis: a systematic review.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »